hederagenin has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Li, Y; Liang, J; Lin, X; Liu, Q; Song, F; Su, Y; Tian, K; Wang, D; Wang, Z; Xu, J; Zhan, Y; Zhao, J | 1 |
1 other study(ies) available for hederagenin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.
Topics: Animals; Bone Resorption; Female; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Oleanolic Acid; Osteogenesis; Ovariectomy; Protective Agents; RANK Ligand; Signal Transduction | 2020 |